STS ⅡA inhibited angiogenesis of lung adenocarcinoma by activating FOXO3 to inhibit CXCL1/STAT3/VEGF pathway

CONCLUSION: Our study finally elucidated the underlying molecular mechanism by which STS ⅡA inhibits LUAD angiogenesis.PMID:38253207 | DOI:10.1016/j.toxicon.2024.107627

Source: Toxicon - January 22, 2024 Category: Toxicology Authors: Bu Wang Fang Zou Gu Xin Bao-Li Xiang Jian-Qing Zhao Sheng-Fang Yuan Xiu-Long Zhang Zhi-Hua Zhang Source Type: research